Analytical Data
-
Gene name
Il1f10
- Application
-
Alternative Names
Il1f10Interleukin-1 family member 10; IL-1F10
-
Species
Mouse
-
Source
E. coli
-
Tag
N- His-SUMO
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
Q8R459
-
Expression Region
1-152aa
-
Molecular Weight
33.1 kDa
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
IL1F10, also known as interleukin 1 family member 10 or IL-1F10, is a cytokine that belongs to the interleukin-1 (IL-1) family. It plays a crucial role in modulating immune responses and has been implicated in various inflammatory and autoimmune diseases. Originally identified for its anti-inflammatory properties, IL1F10 is believed to act as a negative regulator of pro-inflammatory cytokines, thus influencing the balance of the immune response. Research has indicated that IL1F10 may be involved in the resolution of inflammation and the promotion of tissue repair, making it a potential therapeutic target for conditions characterized by chronic inflammation. Additionally, its expression patterns in different tissues and during various disease states have garnered attention, leading to investigations of its role in immune regulation and potential implications in pathologies such as inflammatory bowel disease, rheumatoid arthritis, and other auto-inflammatory disorders. Recombinant IL1F10 proteins are being developed for further studies to elucidate its mechanisms of action, therapeutic potential, and applications in clinical settings, highlighting the need for a deeper understanding of this cytokine in the context of immune system modulation and disease intervention.
